Ranga Reddy

Statistics

Publications

Citations

201

H-Index

Active since

2002

Affiliations

Aegera Therapeutics (Canada)(Current)

McGill University

Ranga Reddy is an author at Aegera Therapeutics (Canada) specializing in enzyme inhibition, antibacterial pharmacology, and novel antibacterial drug discovery.

Publications per year

2002–2008

Publications

Triaminotriazine DNA helicase inhibitors with antibacterial activity

Geoffrey A. McKay, Ranga Reddy, Francis F. Arhin et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 56 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Asymmetric Synthesis of the Highly Methylated Tryptophan Portion of the Hemiasterlin Tripeptides

Ranga Reddy, James B. Jaquith, Venugopal Rao Neelagiri et al. · Organic Letters · 2002 · 46 citations

Natural Sciences, Biochemistry, Chemistry +7

A new class of small molecule RNA polymerase inhibitors with activity against Rifampicin-resistant Staphylococcus aureus

Francis F. Arhin, Odette Bélanger, Stéphane Ciblat et al. · Bioorganic & Medicinal Chemistry · 2006 · 40 citations

Life Sciences, Molecular Biology, Pharmacology +13

Bisphosphonated Benzoxazinorifamycin Prodrugs for the Prevention and Treatment of Osteomyelitis

Ranga Reddy, Evelyne Dietrich, Yanick Lafontaine et al. · ChemMedChem · 2008 · 27 citations

Medicine, Medicinal Chemistry, Orthopaedic Surgery +17

Novel non-nucleobase inhibitors of Staphylococcus aureus DNA polymerase IIIC

Yannick Rose, Stéphane Ciblat, Ranga Reddy et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 19 citations · Full text

Life Sciences, Microbiology, Molecular Biology +12

1–5 of 6